Dr. Mike Murray is board certified in Internal Medicine and Medical Genetics and he joined Geisinger Health System as the director of clinical genomics after serving on the faculty at Harvard Medical School and as the clinical chief of genetics at Brigham and Women’s Hospital in Boston for nine years. Mike was born and raised in Philadelphia PA. He earned his medical degree at Penn State Hershey, and went on to do additional training at Cleveland Clinic, University of Pennsylvania, and Harvard Medical School. At Geisinger he led the GenomeFIRST return of results program for the over 125,000 patient participants who undergo Genomic Sequencing as part of the MyCode Community Health Initiative. This project builds on the collaboration between Geisinger and Regeneron Pharmaceuticals, but is funded outside of that research collaboration through internal Geisinger support, external grants, and generous donations. The GenomeFIRST return of results program expects to deliver important risk information based on genetic sequence back to between 2-4% of MyCode participants in its initial phase.
He is now Professor of Genetics and Director for Clinical Operations in the Center for Genomic Health at Yale University.
EDUCATION & TRAINING
MD Pennsylvania State University (1988)
Fellow Harvard Medical School
Fellow University of Pennsylvania
Resident Cleveland Clinic
Board Certification AB of Internal Medicine, Internal Medicine (1991)
Board Certification AB of Medical Genetics and Genomics, Clinical Genetics (2002)